These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Improvement of endothelial function in a murine model of mild cholesterol-induced atherosclerosis by mineralocorticoid antagonism. Kratz MT; Schirmer SH; Baumhäkel M; Böhm M Atherosclerosis; 2016 Aug; 251():291-298. PubMed ID: 27439215 [TBL] [Abstract][Full Text] [Related]
5. Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice. Baumhäkel M; Custodis F; Schlimmer N; Laufs U; Böhm M Atherosclerosis; 2010 Sep; 212(1):55-62. PubMed ID: 20347444 [TBL] [Abstract][Full Text] [Related]
6. The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice. Lee IO; Kratz MT; Schirmer SH; Baumhäkel M; Böhm M J Pharmacol Exp Ther; 2012 Nov; 343(2):253-7. PubMed ID: 22837011 [TBL] [Abstract][Full Text] [Related]
7. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898 [TBL] [Abstract][Full Text] [Related]
8. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241 [TBL] [Abstract][Full Text] [Related]
9. Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice. Ganbaatar B; Fukuda D; Salim HM; Nishimoto S; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Soeki T; Sata M Atherosclerosis; 2018 Aug; 275():124-132. PubMed ID: 29902700 [TBL] [Abstract][Full Text] [Related]
10. Chronic Cadmium Exposure Accelerates the Development of Atherosclerosis and Induces Vascular Dysfunction in the Aorta of ApoE Oliveira TF; Batista PR; Leal MA; Campagnaro BP; Nogueira BV; Vassallo DV; Meyrelles SS; Padilha AS Biol Trace Elem Res; 2019 Jan; 187(1):163-171. PubMed ID: 29707746 [TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice. Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640 [TBL] [Abstract][Full Text] [Related]
12. NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice. Grootaert MOJ; Schrijvers DM; Van Spaendonk H; Breynaert A; Hermans N; Van Hoof VO; Takahashi N; Vandenabeele P; Kim SH; De Meyer GRY; Martinet W Atherosclerosis; 2016 Sep; 252():166-174. PubMed ID: 27425215 [TBL] [Abstract][Full Text] [Related]
13. Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo. Hoyer FF; Steinmetz M; Zimmer S; Becker A; Lütjohann D; Buchalla R; Zimmer A; Nickenig G J Mol Cell Cardiol; 2011 Dec; 51(6):1007-14. PubMed ID: 21884703 [TBL] [Abstract][Full Text] [Related]
14. Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals. Christodoulou E; Kadoglou NPE; Stasinopoulou M; Konstandi OA; Kenoutis C; Kakazanis ZI; Rizakou A; Kostomitsopoulos N; Valsami G Atherosclerosis; 2018 Jan; 268():207-214. PubMed ID: 29128090 [TBL] [Abstract][Full Text] [Related]
15. Perillaldehyde prevents the formations of atherosclerotic plaques through recoupling endothelial nitric oxide synthase. Yu L; Liu H J Cell Biochem; 2018 Dec; 119(12):10204-10215. PubMed ID: 30171746 [TBL] [Abstract][Full Text] [Related]
16. Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice. Krogmann AO; Lüsebrink E; Steinmetz M; Asdonk T; Lahrmann C; Lütjohann D; Nickenig G; Zimmer S PLoS One; 2016; 11(1):e0146326. PubMed ID: 26751387 [TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice. Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329 [TBL] [Abstract][Full Text] [Related]
18. Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice. Zhao LY; Li J; Yuan F; Li M; Zhang Q; Huang YY; Pang JY; Zhang B; Sun FY; Sun HS; Li Q; Cao L; Xie Y; Lin YC; Liu J; Tan HM; Wang GL Mar Drugs; 2015 Apr; 13(4):2306-26. PubMed ID: 25874925 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice. Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139 [TBL] [Abstract][Full Text] [Related]